AI assistant
Sending…
Tonix Pharmaceuticals Holding Corp. — Director's Dealing 2013
May 30, 2013
33543_dirs_2013-05-30_8be68540-2c56-4319-a67a-b345434a784f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK: 0001430306
Period of Report: 2013-05-29
Reporting Person: DAUGHERTY BRUCE (SEE REMARKS)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-29 | Common Stock, $0.001 par value | P | 100 | $7.25 | Acquired | 10609 | Direct |
More from Tonix Pharmaceuticals Holding Corp.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 15
Earnings Release
2026
May 11
Interim / Quarterly Report
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 7
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Mar 31